Model Checkpoint Epoch: 3.0
Evaluation Model Used: gpt-5-mini
Number of Prompts Printed: 5
Number of Prompts Used for Calculating the Average for Each Metric: 20
QLoRA Adapter Configuration:
	Rank: 32
	QLoRA Alpha: 32.0 

================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Undernutrition in neonates increases the risk of serious morbidities. The objective of this study was to describe neonatal morbidity associated with low body fat percentage (BF%) and measure the number of undernourished neonates defined by BF% and compare this with birth weight percentiles (<10th). Eligibility included term (≥37 wk) neonates. BF% measurements were undertaken by air displacement plethysmography. Data on neonatal outcomes were extracted from medical records and used to develop a measure of neonatal morbidity. We assessed the association between neonatal morbidity and population-based birth weight percentiles compared with the BF% measurements. Five hundred and eighty-one neonates were included. Low BF% was defined by 1 SD below the mean and identified in 73 per 1,000 live births. Neonatal morbidity was found in 3.4% of neonates. Birth weight percentile was associated with neonatal morbidity (odds ratio (OR): 1.03 (95% confidence interval (CI): 1.01, 1.05); P =<0.001). BF% was associated with a higher risk of neonatal morbidity (OR: 1.30 (95% CI: 1.15, 1.47); P =<0.001).
Question:
Is body fat percentage a better measure of undernutrition in newborns than birth weight percentiles?
[/INST]

Generated Answer: Neonatal undernutrition is common, with an estimated 1 SD below the mean BF% being associated with 73/1,000 live births. BF% may be a more accurate measure of undernutrition than birth weight percentiles because it is less susceptible to confounding factors such as gestational age, ethnicity, and maternal BMI. However, BW% should also be considered when assessing undernutrition in neonates. Further studies are needed to determine whether BF% or BW% is most useful for identifying neonatal undernutrition and determining its clinical significance.

Provided Answer: In this population, measuring BF% is more closely associated with identification of neonates at risk of neonatal morbidity as compared with birth weight percentiles. BF% measurements could assist with identifying neonates who are appropriately grown yet undernourished and exclude small neonates not at risk. 

correctness: 0.6
Reasoning:
The assistant's response is partially correct but incomplete and includes an unsupported claim. It correctly notes that low BF% identified a substantial proportion (73 per 1,000) and suggests BF% may be a better measure than birth weight percentiles, but it fails to state the study's main finding clearly — that BF% was more closely associated with neonatal morbidity than birth weight percentiles and can identify neonates who are appropriately grown yet undernourished (and exclude small neonates not at risk). The statement that BF% is "less susceptible to confounding" by gestational age, ethnicity, and maternal BMI is not supported by the provided study summary. The hedging about needing further studies is reasonable but unnecessary for answering the specific question based on the presented results.

conciseness: 0.8
Reasoning:
The assistant's reply is concise and directly answers the question by stating that BF% may be a more accurate measure than birth weight percentiles and noting reasons why (less confounding). It is slightly hedged ("may be") and omits the study's comparative effect sizes (ORs) and the specific conclusion that BF% was more closely associated with neonatal morbidity, but overall it stays to the point.

relevance: 0.6
Reasoning:
The assistant's answer is partially relevant: it addresses the question and correctly cites a real figure from the context ("1 SD below the mean BF% ... 73/1,000 live births"), but it does not explicitly reference the reported stronger association (ORs) showing BF% is more closely linked to neonatal morbidity than birth weight percentiles. The response also adds an unreferenced claim about BF% being "less susceptible to confounding" (gestational age, ethnicity, maternal BMI), which is not stated in the provided context. Overall the answer is reasonable but incomplete and includes an unsupported assertion.

coherence: 0.7
Reasoning:
The reply is generally coherent and well-structured: it answers the question directly (BF% may be a better measure), gives a supporting rationale, and adds an appropriate caveat. However, it uses slightly imprecise wording ("associated with 73/1,000" instead of "identified in 73/1,000"), omits the study's key quantitative evidence (the stronger odds ratio for BF% vs birth weight percentile), and asserts reasons (less susceptibility to confounding) without tying them to the presented data. Overall it communicates the conclusion clearly but could be improved by citing the study's specific findings and avoiding unsupported assertions.

helpfulness: 0.6
Reasoning:
The assistant's reply is partially helpful: it correctly suggests that BF% may be a better indicator than birth weight percentiles, but it is vague and omits key study evidence. It fails to report the study's stronger association (BF% OR 1.30 vs birth weight percentile OR 1.03) and the finding that low BF% identified 73 per 1,000 neonates at risk. The comment about confounding (gestational age, ethnicity, maternal BMI) is speculative here because those specifics weren't provided in the question context. The conclusion ("further studies needed") is reasonable, but the response could be clearer and more closely tied to the reported results.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
We retrospectively collected and analyzed data of all diabetic patients affected by Charcot neuroarthropathy in combination with critical limb ischemia, which arrived to our care for the presence of foot lesions and underwent endovascular revascularization, followed by surgical and orthopedic treatment between January 2010 and January 2012. The primary end point was to assess the limb salvage rate. The secondary end point was to evaluate the healing time of the lesions. Ten diabetic patients (10 men; mean age 69.1±8.5 years), affected by ischemic Charcot neuroarthropathy underwent endovascular revascularization, surgical debridement and orthopedic correction. The limb salvage rate was 90%, avoiding major amputation in 9 patients. In one patient (10%) the infection could not be controlled and below-the-knee amputation was carried out. The required time to heal the lesion was in mean 197.4±22.4 days, after revascularization, surgical and orthopedic treatment.
Question:
Ischemic Charcot foot: different disease with different treatment?
[/INST]

Generated Answer: The limb salvage rate was very high, but it seems that one patient needed lower extremity amputation due to persistent infection. This suggests that the management of this pathology may require different treatment strategies. It would be important to investigate the etiologic factors of this infection and to develop specific protocols for its prevention or treatment. The results also suggest the need for a multidisciplinary approach in treating this condition. Further studies on the natural history of Charcot neuroarthropathy with critical limb ischemia and their correlation with the prognosis of the infection would be useful to improve the therapeutic options. These results also highlight the importance of early diagnosis and prompt intervention in order to achieve better results.
In addition, the results should encourage us to reflect on the current indications for surgery and orthopedics in these cases and to think about how they can be modified according to the results obtained here. The results could be used to improve the clinical guidelines and treatment protocols for these conditions. We have to consider the possibility that a multidisciplinary team will be necessary for the management of this pathology.
Moreover, we should consider the fact that the treatment of ischemic Charcot neuroarthropathy requires a multidisciplinary approach including vascular surgeons, orthopedic surgeons, plastic surgeons, podiatrists, and infectious diseases specialists. In particular, the role of the orthopedic surgeon has been less investigated than other specialties, although the lesions of Charcot neuroarthropathy often involve the bones and joints, and the surgical treatment of these lesions is crucial. The results of this study confirm the importance of a multidisciplinary approach to the management of ischemic Charcot neuroarthropathy.
Finally, we have to consider the possibility that the presence of diabetes mellitus may influence the outcome of this condition. Moreover, the results of this study could help to improve the diagnosis and treatment of Charcot neuroarthropathy and critical limb ischemia in general.

Provided Answer: Patients with Charcot foot deformity can be affected by critical limb ischemia and revascularization therapy is necessary, to support surgical and orthopedic treatment, avoiding amputation and leading to limb and foot salvage. 

correctness: 0.7
Reasoning:
The assistant's reply is largely accurate and clinically reasonable: it correctly notes the high limb-salvage rate, the threat posed by uncontrolled infection, and the need for multidisciplinary care (including vascular, orthopedic and infectious-disease input). However, it is somewhat vague and repetitive and fails to explicitly state the key point from the ground truth — that ischemic Charcot foot represents a distinct (ischemic) subset that commonly requires revascularization to support subsequent surgical/orthopedic treatment and improve chances of limb/foot salvage. No factual errors are present, but the answer could be more direct and concise.

conciseness: 0.3
Reasoning:
The response is verbose and repetitive and does not concisely answer the question. It hints at relevant points (high limb-salvage after revascularization, need for multidisciplinary care) but fails to state directly and succinctly that ischemic Charcot foot represents a situation requiring revascularization to support surgical/orthopedic treatment and improve limb salvage. 

relevance: 0.7
Reasoning:
The response is generally relevant: it cites the study's main outcome (high limb salvage with one patient undergoing amputation) and draws appropriate conclusions that ischemic Charcot foot may require different, multidisciplinary management and tailored treatment strategies. However, it is somewhat repetitive, does not explicitly state that revascularization was necessary to support surgical/orthopedic treatment (or report the mean healing time), and could more directly answer "different disease with different treatment?" by clearly affirming that ischemic Charcot often needs combined vascular (revascularization) and orthopedic approaches. 

coherence: 0.6
Reasoning:
The response is generally coherent and organized: it summarizes the study outcome (high limb-salvage with one amputation), advocates for a multidisciplinary approach, stresses early diagnosis and infection control, and suggests further study. However it is repetitive, lacks a clear direct answer to whether ischemic Charcot foot represents a different disease requiring different treatment, and omits the specific, evidence-backed conclusion that revascularization is necessary to support surgical/orthopedic treatment and avoid amputation. Overall useful but somewhat vague and redundant.

helpfulness: 0.4
Reasoning:
The response correctly emphasizes multidisciplinary care, infection control, and early intervention, but it is repetitive, lacks specificity, and does not directly answer the question whether ischemic Charcot foot is a distinct entity requiring different treatment. It fails to state clearly that revascularization is often necessary to support surgical/orthopedic management and enable limb salvage (the key point in the ground truth). The reply is more a restatement of general implications and recommendations for further study than a concise, evidence-linked clinical conclusion.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Radical hysterectomy is recommended for endometrial adenocarcinoma patients with suspected gross cervical involvement. However, the efficacy of operative procedure has not been confirmed. The patients with endometrial adenocarcinoma who had suspected gross cervical involvement and underwent hysterectomy between 1995 and 2009 at seven institutions were retrospectively analysed (Gynecologic Oncology Trial and Investigation Consortium of North Kanto: GOTIC-005). Primary endpoint was overall survival, and secondary endpoints were progression-free survival and adverse effects. A total of 300 patients who underwent primary surgery were identified: 74 cases with radical hysterectomy (RH), 112 patients with modified radical hysterectomy (mRH), and 114 cases with simple hysterectomy (SH). Median age was 47 years, and median duration of follow-up was 47 months. There were no significant differences of age, performance status, body mass index, stage distribution, and adjuvant therapy among three groups. Multi-regression analysis revealed that age, grade, peritoneal cytology status, and lymph node involvement were identified as prognostic factors for OS; however, type of hysterectomy was not selected as independent prognostic factor for local recurrence-free survival, PFS, and OS. Additionally, patients treated with RH had longer operative time, higher rates of blood transfusion and severe urinary tract dysfunction.
Question:
Surgery for endometrial cancers with suspected cervical involvement: is radical hysterectomy needed (a GOTIC study)?
[/INST]

Generated Answer: Radical hysterectomy is recommended in patients with endometrial adenocarcinoma who have suspected gross cervical involvement. This study showed that type of hysterectomy did not affect survival. Patients with RH had longer operative times and higher rates of blood transfusion and severe urinary tract complications. The type of hysterectomy should be carefully considered by physicians to minimize complications while ensuring the best outcomes. Radical hysterectomy is an effective treatment option for patients with suspected gross cervical involvement. Further studies are warranted to validate this finding. We recommend that surgeons carefully consider individual patient characteristics when deciding on the type of surgery. In addition, we suggest that further studies are necessary to evaluate the impact of different types of hysterectomy on outcomes.

Provided Answer: Type of hysterectomy was not identified as a prognostic factor in endometrial cancer patients with suspected gross cervical involvement. Perioperative and late adverse events were more frequent in patients treated with RH. The present study could not find any survival benefit from RH for endometrial cancer patients with suspected gross cervical involvement. Surgical treatment in these patients should be further evaluated in prospective clinical studies. 

correctness: 0.4
Reasoning:
The assistant's reply correctly notes the main findings that hysterectomy type did not affect survival and that radical hysterectomy (RH) was associated with longer operative time and more complications. However, it inconsistently endorses RH as "an effective treatment option" and states RH is "recommended," which is misleading given the study found no survival benefit and higher adverse events; the net implication should be that RH is not clearly needed and decisions should be individualized. The response is also slightly repetitive and lacks explicit mention that hysterectomy type was not an independent prognostic factor for local recurrence-free survival, PFS, or OS.

conciseness: 0.4
Reasoning:
The assistant’s reply states the key findings (no survival difference by hysterectomy type; RH associated with more operative time, transfusion, and urinary dysfunction) but is not concise: it repeats recommendations about considering patient characteristics and further studies, and includes a contradictory statement calling RH “an effective treatment option” despite the study finding no survival benefit. Overall the content could be much tighter and avoid redundancy.

relevance: 0.6
Reasoning:
Explanation: The assistant's reply is largely relevant to the question and cites key findings from the provided context (that type of hysterectomy did not affect survival and that RH was associated with longer operative time, more transfusions, and more urinary complications). However, it is partially inconsistent with the study interpretation: despite the study finding no survival benefit for RH, the assistant still endorses RH as "an effective treatment option," which is misleading given the study could not demonstrate benefit and recommended further evaluation. The answer is also somewhat repetitive and adds generic recommendations without new evidence or exact data from the context.

coherence: 0.4
Reasoning:
Explanation: The response is mostly coherent and organized — it restates the study context, summarizes main findings (no survival difference by hysterectomy type) and notes higher complications with RH. However it contains a clear internal contradiction: it first states that RH did not affect survival yet later asserts that "Radical hysterectomy is an effective treatment option," which conflicts with the study conclusion that RH offered no survival benefit and had more adverse events. The answer is also somewhat repetitive and adds generic recommendations without adding new informational value. Overall it communicates key points but lacks internal consistency and precision.

helpfulness: 0.4
Reasoning:
Explanation: The response correctly notes the study found no survival advantage for radical hysterectomy (RH) and that RH was associated with longer operations and more complications. It also appropriately calls for individualized decision-making and further study. However, it is confused and potentially misleading: it opens by asserting RH is “recommended” and later calls RH “an effective treatment option,” which contradicts the study’s key finding of no survival benefit and higher adverse events. The answer is also repetitive and lacks specific outcome details (e.g., which endpoints were analyzed, the adverse-event types/frequency). It would be improved by removing the unsupported endorsement of RH, explicitly stating that RH offered no survival benefit but had greater perioperative and late morbidity, and by briefly noting the study design and implications for practice.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
The morbidity and mortality of pancreaticoduodenectomy (PD) have significantly decreased over the past decades to the point that they are no longer the sole indicators of quality and safety. In recent times, hospital readmission is increasingly used as a quality metric for surgical performance and has direct implications on health-care costs. We sought to delineate the natural history and predictive factors of readmissions after PD. The clinicopathologic and long-term follow-up data of 1,173 consecutive patients who underwent PD between August 2002 and August 2012 at the Massachusetts General Hospital were reviewed. The NSQIP database was linked with our clinical database to supplement perioperative data. Readmissions unrelated to the index admission were omitted. We identified 173 (15 %) patients who required readmission after PD within the study period. The readmission rate was higher in the second half of the decade when compared to the first half (18.6 vs 12.3 %, p = 0.003), despite a stable 7-day median length of stay. Readmitted patients were analyzed against those without readmissions after PD. The demographics and tumor pathology of both groups did not differ significantly. In the multivariate logistic regression analysis, pancreatic fistula (18.5 vs 11.3 %, OR 1.86, p = 0.004), multivisceral resection at time of PD (3.5 vs 0.6 %, OR 4.02, p = 0.02), length of initial hospital stay>7 days (59.5 vs 42.5 %, OR 1.57, p = 0.01), and ICU admissions (11.6 vs 3.4 %, OR 2.90, p = 0.0005) were independently associated with readmissions. There were no postoperative biochemical variables that were predictive of readmissions. Fifty percent (n = 87) of the readmissions occurred within 7 days from initial operative discharge. The reasons for immediate (≤7 days) and nonimmediate (>7 days) readmissions differed; ileus, delayed gastric emptying, and pneumonia were more common in early readmissions, whereas wound infection, failure to thrive, and intra-abdominal hemorrhage were associated with late readmissions. The incidences of readmissions due to pancreatic fistulas and intra-abdominal abscesses were equally distributed between both time frames. The frequency of readmission after PD is 15 % and has been on the uptrend over the last decade.
Question:
Understanding hospital readmissions after pancreaticoduodenectomy: can we prevent them?
[/INST]

Generated Answer: Hospital readmissions after PD may be preventable by optimizing the perioperative care of the patient. These results should encourage surgeons to adopt measures aimed at reducing readmissions after PD. The most important factors that could reduce readmissions include improved preoperative evaluation, appropriate staging of the disease, reduction of blood loss during operation, use of minimally invasive techniques whenever possible, careful monitoring of the patient's nutritional status, and early detection of complications such as pancreatitis. Surgeons must also ensure that the patient's lifestyle, dietary habits, and comorbidities are optimized before and after surgery. Furthermore, the development of a comprehensive multidisciplinary approach to postoperative care is recommended to improve outcomes. Future prospective studies are needed to evaluate these strategies and determine their impact on readmissions. These results suggest that readmissions after PD can be reduced by improving perioperative care and implementing evidence-based guidelines for PD management. It is essential that surgeons take responsibility for improving the quality of care provided to patients undergoing PD.

Provided Answer: The complexity of initial resection and pancreatic fistula were independently associated with hospital readmissions after PD. Further efforts should be centered on preventing early readmissions, which constitute half of all readmissions. 

correctness: 0.3
Reasoning:
The assistant's reply is overly generic and does not accurately reflect the key findings from the presented study. The study identified pancreatic fistula and complexity of the initial resection (multivisceral resection) as independent predictors of readmission and found that half of readmissions occur within 7 days, so efforts should particularly target preventing early readmissions; the assistant failed to mention these specific, evidence-based predictors or the need to focus on early readmissions and the differing causes of early vs late readmission. Instead the answer offered broad perioperative recommendations not clearly supported by the provided data.

conciseness: 0.3
Reasoning:
The response is verbose and general rather than concise and targeted. It offers broad perioperative recommendations and repeated calls for improved care but fails to state the study’s key findings (that complexity of resection and pancreatic fistula independently predict readmission) or to emphasize preventing early readmissions (≈50% occur within 7 days) and the differing causes of early vs late readmission. It also includes suggestions (e.g., staging, minimally invasive techniques, reducing blood loss) not directly supported by the presented results. Overall it is not succinct or tightly aligned with the ground-truth conclusions.

relevance: 0.3
Reasoning:
The assistant's reply gives a general answer that readmissions after PD "may be preventable" and lists broad perioperative measures, but it fails to refer to or quote the specific, relevant findings from the provided context (for example, that pancreatic fistula and multivisceral resection were independently associated with readmission, and that 50% of readmissions occurred within 7 days). It also includes suggestions (e.g., early detection of pancreatitis) that are not drawn from the context and omits mention of the study's key actionable targets (pancreatic fistula prevention and focus on early readmissions).

coherence: 0.3
Reasoning:
The assistant's reply is generally coherent and provides plausible general strategies for reducing surgical readmissions, but it fails to engage with the actual study findings. It does not mention the key independent predictors identified (pancreatic fistula and complexity/multivisceral resection), nor does it highlight that half of readmissions occur within 7 days and thus that efforts should particularly target early readmissions. Several recommendations are vague or not directly tied to the reported data (for example, “early detection of pancreatitis” rather than focusing on pancreatic fistula), and the answer lacks specific, evidence-linked interventions informed by the study. Overall it is organized but insufficiently specific or aligned with the ground truth.

helpfulness: 0.3
Reasoning:
The response offers general perioperative recommendations that could plausibly reduce surgical readmissions, but it fails to engage with the study's key findings and thus is only modestly helpful. It does not identify pancreatic fistula or complex/multivisceral resection (and other independent predictors like prolonged initial LOS and ICU admission) as specific targets for intervention, nor does it note that half of readmissions occur within 7 days and that early-readmission prevention should be prioritized. Several suggestions are vague or not supported by the presented data (e.g., emphasis on minimally invasive techniques, early detection of pancreatitis), and the answer lacks concrete, study-linked strategies (for example, targeted fistula prevention/management, standardized discharge criteria, early postdischarge follow-up for the first week). Overall the reply is generic rather than evidence-linked.

================================================================================
Average correctness Score: 0.505
Average conciseness Score: 0.55
Average relevance Score: 0.575
Average coherence Score: 0.56
Average helpfulness Score: 0.495
